Ogle G D, Rosenberg A R, Kainer G
Department of Nephrology, Prince of Wales Children's Hospital, Sydney, Australia.
Pediatr Nephrol. 1992 Jul;6(4):394-8. doi: 10.1007/BF00869745.
Growth hormone (GH) affects renal function and kidney growth. Pituitary-derived or recombinant human GH (rhGH), acting via insulin-like growth factor-1 (IGF-1), increases glomerular filtration rate (GFR) and renal plasma flow (RPF) in GH-deficient as well as in normal adults. Furthermore, GFR and RPF are low in hypopituitarism and elevated in acromegaly. These effects of GH on GFR and RPF have not been demonstrated in moderate renal insufficiency. IGF-1 is implicated in compensatory renal hypertrophy. Markedly elevated levels of serum GH accelerate glomerular sclerosis in rodents, although the significance of these findings for GH treatment in humans is uncertain. rhGH therapy offers great promise to children with short stature from various aetiologies. Preliminary reports on the use of rhGH in children with renal disease and after renal transplantation have not shown any consistent change in kidney function, although follow-up times are short. The long-term impact of rhGH therapy on kidney function in short children needs further evaluation.
生长激素(GH)影响肾功能和肾脏生长。垂体来源的或重组人生长激素(rhGH)通过胰岛素样生长因子-1(IGF-1)发挥作用,可增加生长激素缺乏的成年人以及正常成年人的肾小球滤过率(GFR)和肾血浆流量(RPF)。此外,垂体功能减退时GFR和RPF较低,而肢端肥大症时则升高。GH对GFR和RPF的这些影响在中度肾功能不全患者中尚未得到证实。IGF-1与代偿性肾肥大有关。血清GH水平显著升高会加速啮齿动物的肾小球硬化,尽管这些发现对人类GH治疗的意义尚不确定。rhGH治疗为各种病因导致的身材矮小儿童带来了巨大希望。关于rhGH在肾病儿童和肾移植后使用的初步报告未显示肾功能有任何一致的变化,尽管随访时间较短。rhGH治疗对矮小儿童肾功能的长期影响需要进一步评估。